Kolmar Korea Co., Ltd. (161890.KS) KSC
83,400.00
-2100(-2.46%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
83,400.00
-2100(-2.46%)
Currency In KRW
Address
12-11 Doekgogae-gil
Sejong City,
Korea (the Republic of)
Phone
82 4 4860 0532
Website
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
1152
First IPO Date
October 18, 2012
| Name | Title | Pay | Year Born |
| Yongchul Hur | Chief Executive Officer of Kolmar Laboratories, Kolmar USA & CEO of North American subsidiaries | 0 | N/A |
| Hyun-Gyu Choi | Chief Executive Officer, President & Director | 0 | 1960 |
| Yi-Pyo Hong | Senior MD of KMB & Director | 0 | 1966 |
| Philippe Warnery | Global Chief Commercial Officer | 0 | N/A |
| Sang-Geun Han | Vice President & Chairman | 0 | 1973 |
| George Rivera | Chief Science Officer of Kolmar North American subsidiaries | 0 | N/A |
| Inki Park | Head of the R&D Center for North America | 0 | N/A |
Kolmar Korea Co., Ltd. researches, develops, produces, and sells beauty and health products in South Korea and internationally. It offers various cosmetic products, including skin care, makeup, baby, hair care, and body care products, as well as perfume, functional cosmetics, and qusi drugs. The company also provides prescription, over-the-counter, and bioequivalent drugs; drugs for dermatology and circulatory system; ointment and external, and oral solutions; and oral solids. In addition, it offers health functional food comprising health supplements; ingredients; special purpose food; and individually recognized health supplements. The company was founded in 2012 and is headquartered in Sejong, South Korea.